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CUPRIC oxyacetate has been shown to lessen the severity of rat liver damage
caused by 4-dimethylaminoazobenzene (Howell, 1958), 3-methoxyaminoazo-
benzene and its N-methyl analogue (Fare and Howell, 1964) and bythioacetamide
(Fare, 1965) provided that in each case it was given simultaneously with the
hepatotoxin.
The salt was able to reverse in part early established changes caused by 4-di-
methylaminoazobenzene (Fare, 1966) and it has been suggested (Fare, 1964, 1966)
that the protection may involve competitive binding of liver proteins by cupric
ions and metabolites ofingested poison.
In an attempt to determine whether cupric oxyacetate can offer protection
against awide spectrum ofhepatotoxic agents, orwhetheritmerely actsspecifically
against azo dyes and thioacetamide, the salt was fed together with 5 other drugs
reported to have liver-damaging properties. The drugs chosen have widely
differing chemical structures, both among themselves and when compared with
the compounds listed above.
MATERIALS AND METHODS
Copper acetate
Cupric oxyacetate hexahydrate (CuAc) obtained from Hopkin and Williams
Ltd.
Liver poisons
Dimethylnitrosamine (preparedfrom dimethylamine hydrochloride and nitrous
acid); alphanaphthylisothiocyanate (Eastman Kodak); ammonium selenate
(BDH); 2-acetamidofluorene (Light and Co.); DL-ethionine (BDH). The drugs
are abbreviated as DMNA, ANIT, AS, AAF and ETH respectively.
Administration
The drugs were given to albino rats for 5 days each week with proprietary rat
cube being given on Saturdays and Sundays. Experimental diets were prepared
as described by Howell (1958) by adding the requisite chemicals to maize meal
obtained from a local dealer, except for DMNA which, because it is a liquid, was
poured on to the maize meal as an aqueous solution. Numbers of animals, drug
* Present address: Glaxo Laboratories Ltd., North Lonsdale Road, Ulverston, Lancashire.
26doses and periods of feeding are given in Table I. All rats were 3-4 months old
at the start of diet feeding.
TABLE I.-Plan ofExperiment
Average weekly
doses of drugs
Number (mg. per rat) Period of
of , treatment
Group rats Sex Toxin CuAc (months)
Control A 10 . M . - - . 2-24
Control B 10 . M . - 375 . 2-24
IA . 10 . M . 2-5 DMNA . 2-12
lB . 10 M . 2-5 DMNA 375 . 2-12
2A . 10 . M . 70 ANIT 1-17
2B . 10 . M . 70 ANIT 375. 1-17
3A . 10 M . 2-5 AS . 4-26
3B . 10 M . 2-5 AS 375 . 4-26
4A . 12 . M . 25 AAF - . 1-12
4B . 12 . M . 25 AAF 375. 1-12
5A . 11 .F. 150 ETH . 1-24
5B . 11 . F . 150 ETH 375. 1-24
Determination of liver damage
At intervals, rats were killed from each group. Body and liver weights were
recorded, as was the naked eye appearance of the liver. Representative pieces of
the liver were fixed in formol-saline, embedded in paraffin, cut at 5 u and stained
with haematoxylin and eosin for histological examination. In certain cases, pieces
ofliver were processed for histology by the " frozen section " technique. The rest
of the liver was homogenised in distilled water to give a concentration of 10 per
cent.
Other tissues were taken for histology only when macroscopically abnormal.
The liver homogenates were assayed for copper, protein, total fat, phospholipid,
total cholesterol, water and riboflavin contents.
Chemical methods
Riboflavin was extracted from a deproteinised sample of homogenate with
phenol, returned to aqueous solution and determined fluorimetrically against a
quinine standard.
Water and total fat were determined by the method of Sperry (1954) and
protein by micro-Nesslerisation after Kjeldahl digestion.
Total cholesterol was determined by the ferric chloride reaction as described by
Crawford (1958). Phospholipids were extracted by the method of Aiyar et al.
(1964) and determined by perchloric acid digestion followed by phosphorus assay
by the method of Holman (1943).
Copper was determined by the method of Fare (1964) using the colorimetric
reaction with biscyclohexanoneoxalyldihydrazone described by Nilsson (1950).
RESULTS
General
All the rats thrived on the experimental diets and weight gains were identical
to those found for the two control groups, with the exceptions of those rats given
ETH with or without copper. After treatment for 2 years, i.e. when the surviving
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pair were 27-28 months old, their body weights were only equivalent to the normal
weight of a 6 month old animal ofthe same sex.
Livers increased in size as tissue damage progressed, and the decrease in body
weight to liver weight ratio was used as one of the criteria of the amount of this
damage for all rats, except for those two groups receiving ETH (Fig. 1). These
latter animals showed a slight decrease in liver weight proportionate to their body
weight (Table II).
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FIG. 1.-Body weight to liver weight ratios ofrats fed 4 hepatotoxins with (0*) andwithout (0)
oxyacetate for various times. Details of diets are given in Table I. Normal value (control
group A) 27
-O, standard deviation 2 9.
Pathology
Rats for killing were selected at random at appropriate intervals. There were
no adventitious deaths, nor did any animal have to be killed at any time in pre-
ference to its cage mates for humanitarian reasons, since preliminary experiments
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TABLE II.-Ratio ofBody Weight to Liver Weight, Post Mortemn,
ofRats Fed the ETH and ETH + CuAc Diets
Period of Weight ratio
treatment , -
(months) ETH alone ETH + CuAc
1 . 26-7 25-5
3 28-3 28-2
7 . 24-4 24-8
9 . 22 9 27-7
10 . 28- 5 28- 7
12 28-0 28-3
14 . 30-3 28-2
16 . 29- 8 29-1
18 . 28-2 28-6
20 31-4 27-9
24 . 31- 8 31-4
Mean 28- 2 Mean 28- I
Control group A gave a mean value 27 0,
standard deviation 2- 9 (maize fed, no toxin or
CuAc included).
had been carried out to indicate what dose rates could safely be used without
undue toxicity. With due allowance for the " individuality " of any animal with
respect to response to drug treatment, it can therefore be assumed that the animal
killed at any time was typical of the whole surviving group.
(i) DMNA:-Macroscopically and microscopically the livers from the rats
killed after 2, 3 and 6 months treatment with DMNA alone showed no detectable
pathological change. Those killed after 5, 7, 8, 10, 11 and 12 months all had
enlarged livers showing gross damage.
Damage in any one organ was not uniform from lobe to lobe, such that several
pieces had to be taken from each liver to get a reasonable overall assessment of
histological changes, and damage was generally more severe after longer periods of
treatment.
Without exception, all the damaged livers contained areas of cystic tumour
(cystadenoma) and regeneration nodules. The last 3 animals killed (after 10-12
months treatment) had livers with a very coarse surface. Histologically, this was
found to be a well-marked cirrhosis without much fibrosis; extensive bile duct
proliferation was also found in these 3 livers. Lobular disorganisation ranging
from moderate to severe was found in all 7 damaged livers and a wide range of cell
size wasnoted, particularly in thelast rat killed (12 months treatment) where large,
dark-stained cells were prevalent.
No apparent damage was caused to other organs, except that spleenswereoften
grossly enlarged.
When CuAc was given also, the livers appeared quite smooth with no evidence
of regeneration nodules or cystadenoma, and they did not increase in weight as
diet feeding continued (Fig. 1).
Histologically, 3 of the livers were reported as normal and there were no
connective tissue changes in any of the others after feeding DMNA + CuAc.
There was a suggestion of lobular disorganisation in 3 of them, but parenchymal
cells in general appeared healthy apart from a sprinkling of pycnotic cells and
occasional large cells.
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(ii) ANIT:-The most obvious feature in the rats fed ANIT alone was that liver
damage visible to the naked eye-a roughening of the surface, an increase in size
and a marked hardening in consistency- was the same in the first rat killed (after
1 month) as in all the others up to the last killing after 17 months treatment.
Histological examination at 1 month showed proliferation of large bile ducts
in and away from the portal systems. There was early multilobular cirrhosis
with little associated fibrous tissue. Slight lobular disorganisation was present
and pycnotic cells, mostly large, were quite numerous.
At 2 months, similar but more advanced changes were noted with the walls of
original bile ducts showing hyaline fibrosis, and the presence of definite regenera-
tion nodules. After 5, 7 and 9 months, large bile duct proliferation was still the
main feature but there was also a greater degree of lobular disorganisation than
hitherto. Regeneration nodules were more numerous and cirrhosis was now
well-marked. After 11-17 months treatment, the bile duct proliferation was less
conspicuous. Parenchymal disorganisation had increased, but the lobular pattern
was still in the main recognisable.
The animals fed ANIT + CuAc also showed evidence of liver damage when
killed, and again the apparent extent was little changed by continued treatment.
The livers increased in size much more slowly in this group and the consistencies
were more nearly normal and the surfaces smoother than the corresponding findings
from the group given ANIT alone. The copper salt delayed, but did not prevent,
the portal bile duct proliferation caused by ANIT. There also appeared to be less
parenchymal fibrosis in the ANIT + CuAc series. The weight ratio showed less
change when CuAc was included in the diet (Fig. 1).
(iii) AS:- Apart from a little loss of hair, treatment with this compound was
without effect. The livers and all the other organs appeared quite normal and the
body weight to liver weight ratio remained in the normal range throughout
treatment for over 2 years. when either the AS or the AS + CuAc diet M as fed
(Fig. 1).
(iv) AAF:-Macroscopically, the livers ofAAF-treated rats appeared abnormal
from the third month of treatment onwards. An increase in liver size was a pro-
minent feature, even in the early stages before tumours developed (Fig. 1). Gross
tumours were seen from 5 months onwards of both solid and cystic appearance,
and damage was more evenly distributed between the various regions ofindividual
livers than was the case with DMNA. Three rats developed " ear duct " tumours,
other organs remained healthy.
Microscopically the first changes noted (after 1 month) was early periportal
fibrosis with little change in the parenchyma, but by 3-4 months there was patchy
degeneration ofthe parenchyma with some loss of architecture, and the periportal
fibrosis was much more advanced.
At 5 months, multilobular cirrhosis became more general and the architectural
disorganisation more severe, and from this time onwards tumours appeared.
Areas of cholangiofibrosis were found in 4 livers, cystadenomatosis in 5, cholangio-
carcinoma in 3 and hepatoma in 3.
When CuAc was given also, the livers did not increase in size to such a marked
extent (Fig. 1) and macroscopic damage was much less. Portal fibrosis was found
to be slight in 2 livers and absent in the other 10. Lobular disorganisation likewise
was definite in only 1 liver, slight in 5 others and absent in the remainder. Rudi-
mentary cystadenomata were found in 1 liver and cystadenomatosis in 2 (after 10
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and 11 months). Cholangiofibrosis, cholangiocarcinoma and hepatoma were all
absent.
As with AAF alone, 3 ear duct tumours were found in the 12 rats.
(v) ETH:-Although the livers ofall rats killed after ETH administration with
or without CuAc appeared quite normal to the naked eye, there were some histo-
logical changes. When ETH was given alone, round cell infiltration of portal
systems was seen as the earliest change followed at 3-6 months by lobular dis-
organisation, sometimes slight, sometimes moderate in extent. After 7 months,
there were slight portal fibrosis and bile duct proliferation, but no more advanced
changes resulted from continued treatment for a further 17 months.
The changes that did occur with ETH, though relatively slight compared with
those causedbyDMNA, ANIT andAAF, werereduced stillfurtherbythe inclusion
ofcopper in the diet. Very slightround cell increase in portal systems was present
in 1 liver and slight lobular disorganisation in 2 others. The remaining livers
showed no abnormalities.
Chemical
There was a progressive fall in liver protein in the groups given DMNA, ANIT
and AAF when expressed in terms of nitrogen per weight of wet liver (Fig. 2).
In each case the fall was limited when copper was included in the diet.
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FIG. 2.-Protein content of livers, expressed as mg. nitrogen per g. wet liver, from rats fed
3 toxins with (*) and without (0) cupric oxyacetate for various times. Details ofdiets are
given in Table I. Normal values (control groups A and B) 33-3 and 33- 8 respectively,
standard deviations 25 8 and 2- 9.
Water content rose gradually in damaged livers (Fig. 3) when AAF and DMNA
were used as the toxins, but hardly at all when ANIT was used. This may be
related to the fact that the latter drug alone of these three did not produce any
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FIG. 3.-Water content of livers, expressed as a percentage of the wet weight, from rats fed
3 toxins with (0) and without (0) cupric oxyacetate for various times. Details of diets are
given in Table I. Normal values (control groups A and B) 69-7 and 68 6 respectively,
standard deviations 3- 6 and 3 9.
Riboflavin levels showed a good deal of variation among the animals from
any group, including both the control groups. No trends were apparent, and
although the mean values from the groups fed ANIT alone, AAF alone and DMNA
alone were all low compared with the controls, the differences were found not to be
significant (Table III). This table also gives the results of total fat, phospholipid
TABLE III.-Mean Levels of Total Fat, Phospholipid, Total Cholesterol and Ribo-
flavin in the Livers of Rats Fed Five Liver-damaging Agents With and
Without Cupric Oxyacetate
Group*
Control A
Control B
ANIT
ANIT + CuAc
DMNA
DMNA + CuAc
AAF
AAF + CuAc
AS
AS + CuAc
ETH
ETH + CuAc
Total fat
mg./g. wet liver
58-3 (6 8)
59-2 (60)
64-3 (5.4)
59-4 (4 7)
64-4 (7-1)
60- 3 (6 6)
63-7 (6 2)
59.8 (6 5)
55-4 (4-1)
59-3 (6 3)
63- 6 (7 3)
59- 8 (5 8)
Phospholipid
mg./g. wet liver
26- 0 (3 7)
25- 8 (2 6)
24-7 (3-1)
25-3 (3.4)
25-7 (2 2)
26- 6 (4 0)
25-4 (2 6)
24- 8 (3 3)
27-2 (3 0)
26 9 (2 8)
23- 7 (3 6)
26- 0 (2 9)
Total cholesterol
mg./g. wet liver
3-27 (0-21)
3 40 (0 29)
3-61 (0-31)
3- 44 (0 26)
3- 34 (0 24)
3-19 (0.19)
3- 44 (0 30)
330 (0.22)
3- 17 (0 27)
3-41 (0 27)
3 70 (0 32)
3- 44 (0- 18)
Riboflavin
arbitrary
units/g. wet
liver
66-7 (50)
70 0 (4 3)
60-3 (3 7)
69-5 (5 2)
57 - 6 (4 6)
66-0 (5 0)
58-1 (2.9)
72 - 2 (4 8)
75-3 (3 9)
70-1 (4-4)
70-8 (4 9)
73-0 (5-1)
* Details ofdiets are given in Table I.
Values in parenthesis are standard deviations.
and total cholesterol assays. As with riboflavin, results were erratic and the
means showed no significant differences. There appeared to be more total fat in
the livers from rats treated with ANIT, DMNA, AAF and ETH all without copper,
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2and more total cholesterol in rats fed ANIT and ETH, again without copper in
each case.
Fig. 4 gives the copper contents of the livers as diet feeding of the copper-
supplemented regimens progressed. There was less binding of copper when
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FIG. 4.-Copper content of livers, expressed as ug. Cu per g. wet liver for rats fed CuAc alone
(*) and together with DMNA (0), ANIT (A), AS (A), AAF(E) and ETH (LO). Details of
diets are given in Table I. Normal value (control group A) 3.96, standard deviation 0-12.
CuAc was fed together with ANIT, AAF and DMNA than resulted when the salt
was given with AS and ETH. Rats given the maize + CuAc diet (control group
B) gave the highest storage in a given time.
The livers of rats fed the five drugs without additional copper all had copper
contents identical with those from the control group A animals which were fed
maize alone.
DISCUSSION
Pathology
A notable feature in the case of every drug treatment is that the toxin did
not produce very advanced changes. This was done deliberately since in these
laboratories we are primarily interested in the early stages of carcinogenesis and
the levels of drugs fed were chosen such that severe damage to livers would only
be expected atthe end of 1-2 years treatment. This has the added advantagethat
no rats died oftoxicity or ofinfection and other adventitious causes aggravated by
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severe chronic poisoning, and also that a rat can be selected from each group
completely at random at any desired time for killing. No choice of animal was
imposed by humanitarian reasons.
(i) DMNA: DMNA was found to be toxic in the rat within 5-6 weeks at
200 p.p.m. (Magee and Barnes, 1956) and within 9-14 weeks at 100 p.p.m. At
50 p.p.m. 19 out of 20 rats developed primary liver tumours by 40 weeks and
metastases were found in 7 cases. The same authors (Magee and Barnes, 1959)
produced kidney as well as liver tumours in rats given high doses of DMNA for
short periods, and Zak et al. (1960) obtained liver, kidney and lung tumours under
similar high dose conditions.
At doses of 10 and 20 p.p.m., Magee and Barnes (1959) produced 7 liver and no
kidney tumours in 11 rats treated for 26 months. The dose used this present
experiment corresponds to about 30 p.p.m., and the amount of liver damage
resulting and the absence ofdamage to other tissues is therefore in agreement with
the above previous work.
Although liver damage was normally localised with this drug in one or more
lobes, or parts of lobes, it was not in our experience found to be necessarily more
severe in the left than in the right lobe as reported by Magee and Barnes (1956).
There seemed little doubt that the additional feeding of copper delayed the
liver damage, but did not prevent it entirely.
(ii) ANIT:-The concentration of ANIT used in these experiments was the
same as that of previous workers (Lopez and Mazzanti 1955; McClean and Rees,
1958).
Unlike McClean and Rees (1958) we did not lose 20 per cent of our rats during
the first few weeks nor did they grow more slowly than control animals given
maize only. The liver damage produced, however, was similar, i.e. an increase in
liver size, consistency and nodularity; a miore rapid increase in damage in the
earlier stages of treatment; a lack of tumours even after prolonged treatment
and bile duct proliferation as the main histological feature.
As with DMNA, CuAc delayed but did not ultimately prevent the liver damage.
Again as with DMNA, and as reported by McClean and Rees (1958), no other organs
were affected by the drug, with or without CuAc, apart for splenic enlargement.
(iii) AS:- Nelson, Fitzhugh and Calvery (1943) reported that potassium
ammonium selenide incorporated at dietary levels of 5, 7 or 10 p.p.m., i.e. from
3-6 p.p.m. elemental seleniurni, induced cirrhosis in rats. After 2 years 11 of 53
animals had hepatic tumours and a further 4 had marked hyperplastic changes.
Our rats received 35 p.p.m. of ammonium selenate corresponding to 15 p.p.m.
Se, yet this triple dose was totally ineffectual, so far as liver damage was concerned,
during treatment for up to 26 months. Possible explanations are that the 2 strains
of rats have different susceptibilities to selenium, or that selenium is toxic to rat
liver only when given as certain specific compounds, including potassium ammo-
nium selenide but excluding ammonium selenate.
(iv) AAF: The carcinogenicitv of AAF was first reported by Wilson, DeEds
and Cox (1941) and subsequently a voluminous literature has accumulated (see
Weisburger and Weisburger, 1958, for a review). The drug has been given to
various species by a variety of routes. When fed to rats, tumours have been
reported arising from liver, mammary gland, acoustic duct, facial epidermis,
ureter, kidney, colon, pancreas, lung and other tissues. In the rats used in these
laboratories, the commonest sites of tumour incidence are the first three in the
577above list. Further, in male rats as in this experiment, mammary tumours are
rare and the liver is the main target with occasional involvement of the ear duct.
The additional administration ofcopper had no effect on the incidence ofthese
acoustic duct tumours. This was also found to be so for 3-methoxy-4-aminoazo-
benzene and its N-methyl analogue (Fare and Howell, 1964), two other compounds
which attack both liver and ear duct together with other tissues. Again as
reported by these authors, the ear duct tumours were invariably unilateral.
The copper salt was, however, effective in delaying the liver damage caused by
AAF. Indeed, the partial protection offered was considered to be ofa higher order
for AAF than for DMNA, ANIT and ETH. In contrast, Goodall (1964) obtained
no protection against the non-acetylated analogue of AAF, 2-aminofluorene,
" painted " on the skin when cupric acetate was given in the drinking water.
Protection was given against neither hepatoma nor liver injury.
Whilst it is possible that the disparity in results may be due to different rat
strains, carcinogens and methods ofapplication, it is considered that an important
factor is the difference in copper salts used.
Although the early literature on the subject suggests that the type of copper
salt is unimportant since both copper acetate and sulphate are reported as active
in delaying liver damage prompted by azo dyes (see Howell, 1958, for references),
in these laboratories we have found that the choice of salt is important. The
oxyacetate used (empirical formula Cu(CH3CO2)2.CuO.6H20) gave much higher
liver storage levels ofcopper than did equivalent amounts (with respect to copper)
of more physiological compounds such as the citrate, simple acetate, alginate,
tartrate and lactate as well as copper-glycine and benzoate, and the inorganic salts.
Recently Hopkin and Williams Ltd. have not been able to supply our oxyace-
tate, and we have had to use perforce the cupric acetate manufactured by BDH as
used by Goodall (1964). The resulting liver storage ofcopper has proved markedly
inferior to that resulting from feeding the authentic compound.
(v) ETH:-The subject ofethionine carcinogenesis has been reviewed recently
(Farber, 1963). The same author (Farber, 1956) fed ETH to rats at the same
dosage as that used here for 8-11 months and obtained liver tumours in 12 out of
14 animals.
Ethionine-induced liver damage may be prevented by adding methionine to
the diet (Farber and Ichinose, 1958; Popper et al., 1953), and the former authors
suggested that ETH induces a chronic methionine deficiency in rats which is
reversed by the administration of methionine. The relatively slight effect of
ETH on our rats may therefore be due to a relatively high level of methionine in
the basal diet ofmaize meal used in our experiments.
Chemical
The falls in protein nitrogen as liver damage progressed in the ANIT, AAF and
DMNA treated rats are in agreement with previous work using 4-dimethylamino-
azobenzene and thioacetamide as liver damaging agents (Fare, 1964, 1965). The
falls were limited when copper was fed, again corresponding to previous experience
and correlating with the histological findings.
Part ofthe fall in protein may be accounted for by the higher water content of
the livers in animals treated with AAF and DMNA, but there is still a significant
fall in protein even when expressed in terms of dry liver, particularly in the
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ANIT-treated rats where increase in liver water content was not a noticeable
feature.
Assays of fat, phospholipid, cholesterol and riboflavin in the livers gave no
definite changes in any of these constituents. Although variations in means for
the various groups were found, the differences were not significant. The levels of
the various lipid fractions found were in general agreement with previously pub-
lished results (Cook, 1958; Campbell and Kosterlitz, 1947 ; Tinoco et al., 1965).
It is interesting that when the drugs were fed together with CuAc, the two with
the least effect on the livers, AS and ETH, were the two that more nearly approxi-
mated to CuAc alone as regards liver storage of copper. The three active
compounds when fed with CuAc prevented the liver storage from rising as quickly,
and gives support to the theory that there is competitive protein binding of cupric
ions and toxin or its metabolites. If ETH and AS were ineffectual because they
did not become bound to liver constituents there would be more sites available
on protein and possibly other macromolecules to accommodate copper and hence
give a higher storage.
4-Dimethylaminoazobenzene (Fare and Woodhouse, 1963) and thioacetamide
(Fare, 1965) both prompted increased liver copper storages when fed to rats without
additional copper in the diet. None of the five liver-damaging agents used here
did so, and so increased liver copper content is not a necessary result of feeding a
liver-damaging agent.
Possible copper/drug interactions in vitro
An obvious possibility regarding the mechanism of cupric oxyacetate in
delaying the various liver damaging agents is that copper may inactivate the drug
in question in vitro before it is fed.
This possibility has been ruled out for 4-dimethylaminoazobenzene (Howell,
1958) and thioacetamide (Fare, 1965), but to investigate it for the four active
drugs in this experiment, the following scheme was adopted. Each drug was
incubated with CuAc at 37 degrees for 1 month (diets were normally made up
afresh every fortnight) in the proportions in which they were present in the
experimental diets, under 3 sets of conditions:
(i) An intimate mixture of the two substances.
(ii) Drug + CuAc stored as a solution or suspension in distilled water.
(iii) Drug + CuAc stored as a mixture in maize meal.
In each case (i)-(iii) for each of the 4 effective drugs, the amount present was
assayed before and after the storage treatment.
AAF and ANIT were assayed by means oftheir ultra-violet absorption spectra,
where no changes in peak heights or in the shapes ofthe curves could be detected.
ETH was assayed by thinlayer chromatography on Kieselgel G inphenol/water
followed by spraying with ninhydrin. A copper complex was formed (cf. Fare and
Sammons, 1966) but this reaction is easily reversible at alkaline and acid pH's
and the complex breaks down completely at the pH of gastric juices to yield
ethionine in a 100 per cent yield.
DMNA was also assayed by thin layer chromatography in hexane/ether/methy-
lene chloride as described by Preussmann et al. (1964) using as a detection spray
30 per cent acetic acid containing 1 per cent sulphanilic acid and 0.1 per cent
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alphanaphthylamine. There was no loss of DMNA after incubation with CuAc
under any of the 3 conditions.
Conclusion
Cupric oxyacetate is effective in limiting the extent of rat liver damage
prompted by four drugs ofwidely differing structure, in addition to that prompted
by azo dyes and thioacetamide reported previously.
SUMMARY
1. Five liver-damaging agents-alphanaphthylisothiocyanate, acetamido-
fluorene, dimethylnitrosamine, ammonium selenate and ethionine-were fed to
rats with and without cupric oxyacetate hexahydrate with the following effects:
(a) Ammonium selenate was without effect on the livers.
(b) Ethionine produced microscopic but not macroscopic damage.
(c) The other three remaining drugs produced advanced changes over a period
of several months.
2. In the groups of 10-12 rats used, simultaneous administration ofthe copper
salt limited the liver damage without exception.
3. Falls in liver protein content paralleled the morphological findings, being
more severe when the toxins were fed alone. No significant changes in total fat,
phospholipid, total cholesterol or riboflavin were found.
4. It was established that the drugs were not inactivated by the copper salt
in vitro during storage.
5. When the liver-damaging agents are fed together with copper, the resulting
copper storage levels are in agreement with the suggestion that there may be
competitive binding for available sites in the liver by metabolites of the toxins
and copper.
6. No drug has yet been found which produces rat liver damage by chronic oral
administration in our animals and whose activity is not diminished by CuAc.
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